Headquartered in Melville, NY·Fiscal year ends December·NASDAQ: HSIC·henryschein.com
About Henry Schein
Henry Schein, Inc. (Nasdaq: HSIC) provides products, services and technology platforms to healthcare customers, primarily office-based dental and medical practitioners. It also serves dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
The company reports results across several businesses:
- **Global Distribution and Value-Added Services**: dental merchandise, dental equipment, value-added services and medical distribution, split into U.S. and international operations.
- **Global Specialty Products**: a higher-margin business.
- **Global Technology**: practice management and related technology offerings.
With about 25,000 employees ('Team Schein Members'), it serves more than 1 million customers worldwide with more than 300 business, clinical, technology and supply chain solutions. It runs a centralized, automated distribution network offering more than 300,000 branded and Henry Schein corporate brand products, and has operations or affiliates in 34 countries and territories.
Sales reached $13.2 billion in 2025. The company is a FORTUNE 500 company and an S&P 500 member.
The company is pursuing value creation and restructuring initiatives and has a Strategic Partnership Agreement with KKR Hawaii Aggregator L.P., entered into in January 2025. It is also benefiting from IEEPA tariff refunds. Updated
Henry Schein raised full-year adjusted EPS guidance to $5.50 to $5.56 from $5.29 to $5.39, signaling the dental recovery is taking hold. A tariff refund benefit flattered the quarter's earnings beat.
Pre-Market Stock Futures: Futures are trading higher after a dreadful day on Wall Street, when all the major indices traded lower, and we saw the same pattern that has developed over the…
Henry Schein, Inc. (Nasdaq: HSIC) provides products, services and technology platforms to healthcare customers, primarily office-based dental and medical practitioners. It also serves dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
What is the HSIC stock price target?
24/7 Wall St.'s 12-month price target for HSIC is $112.31, rated Buy. The Wall Street consensus target is $96.87. HSIC price prediction →